Correlation Between Pfizer and Rayliant Quantamental
Can any of the company-specific risk be diversified away by investing in both Pfizer and Rayliant Quantamental at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Rayliant Quantamental into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Rayliant Quantamental Emerging, you can compare the effects of market volatilities on Pfizer and Rayliant Quantamental and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Rayliant Quantamental. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Rayliant Quantamental.
Diversification Opportunities for Pfizer and Rayliant Quantamental
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Rayliant is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Rayliant Quantamental Emerging in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rayliant Quantamental and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Rayliant Quantamental. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rayliant Quantamental has no effect on the direction of Pfizer i.e., Pfizer and Rayliant Quantamental go up and down completely randomly.
Pair Corralation between Pfizer and Rayliant Quantamental
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Rayliant Quantamental. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.07 times less risky than Rayliant Quantamental. The stock trades about -0.39 of its potential returns per unit of risk. The Rayliant Quantamental Emerging is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest 2,232 in Rayliant Quantamental Emerging on January 11, 2025 and sell it today you would lose (143.00) from holding Rayliant Quantamental Emerging or give up 6.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Rayliant Quantamental Emerging
Performance |
| Timeline |
| Pfizer Inc |
| Rayliant Quantamental |
Pfizer and Rayliant Quantamental Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Rayliant Quantamental
The main advantage of trading using opposite Pfizer and Rayliant Quantamental positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Rayliant Quantamental can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rayliant Quantamental will offset losses from the drop in Rayliant Quantamental's long position.| Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
| Rayliant Quantamental vs. SPDR MSCI EAFE | Rayliant Quantamental vs. SPDR MSCI World | Rayliant Quantamental vs. SPDR MSCI USA | Rayliant Quantamental vs. SPDR MSCI Emerging |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |